Solventum Corporation (SOLV)
NYSE: SOLV · Surgical & Medical Instruments & Apparatus · St. Paul, MN · filing with the SEC since 2023
Who owns Solventum Corporation
As filed with the SECHolders of 5% or more
3
3M Company holds 14.8% of Common Stock, as its SCHEDULE 13G/A filed Aug 18, 2025 says.
Directors and officers
20
report now, of 27 people on the record since 2024. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
3M Company
SCHEDULE 13G/A · filed Aug 18, 2025 · Common Stock · 19.9% in Nov 14, 2024
Independent Franchise Partners, LLP
SCHEDULE 13G/A · filed Jan 27, 2026 · Common Stock, Par Value $.01 Per Share · 7.44% in Nov 13, 2025
Vanguard Capital Management
SCHEDULE 13G · filed Apr 30, 2026 · Common Stock
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%
What SOLV reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Acera Surgical
A company bought · acquisition · owns, named in the 10-K filed Feb 27, 2026
113 subsidiaries in 43 countries, from the list filed with the 10-K filed Feb 27, 2026.
Insider tradesForm 4
0sales
1purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$100,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 28 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Wendell Amy Mcbride | director | 0 | $0 | 0 | 1 | $100,000 |